1. Chen PM, Chiou TJ, Fan FS, Liu JM, Hsieh RK, Yen CC, Wang WS. Liu JH. Fulminant hepatitis is significantly increased in hepatitis B carriers after allogeneic bone marrow transplantation. Transplantation 1999; 67(11):1425-33.
2. Chen PM, Chiou TJ, Hsieh RK, Fan FS, Chu CJ, Lin CZ, Chiang H, Yen CC, Wang WS, Liu JH. p53 gene mutations and rearrangements in non-Hodgkin's lymphoma. Cancer 1999; 85(3):718-24.
3. Chen PM, Yang MH, Yu IT, Lin JT, Lin YC, Fan FS, Wang FS, Yen CC, Chiou TJ, Liu JH. Low incidence of BCL-6 gene alterations for diffuse large B cell lymphomas in Taiwan Chinese. Cancer 2002 (in press).
4. Yen CC, Chen YJ, Chen JT, Hsia JY, Chen PM, Liu JH, Fan FS, Chiou TJ, Wang WS, Lin CH. Comparative genomic hybridization of esophageal squamous cell carcinoma: Correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001; 92:2769-77.
5. Liu JH, Yang MH, Fan FS, Yen CC, Wang WS, Chang YH, Chen KK, Chen PM. Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: A phase II study. Urology 2001; 57: 650-4.

曾成槐 醫師　　Cheng-Hwai Tzeng, M.D. 　　民國40年生　　男
學位：	高雄醫學大學醫學院醫學士
進修：	美國華盛頓大學Fred Hutchinson 癌症研究中心 (骨髓移植)
現職：	台北榮民總醫院內科部血液腫瘤科主任
教職：	國立陽明大學內科教授
經歷：	台北榮民總醫院內科部輸血醫學科主任 美國華盛頓大學Fred Hutchinson 癌症研究中心研究員 台北榮民總醫院腫瘤科主治醫師 台北榮民總醫院內科部總醫師 台北榮民總醫院內科部住院醫師
專長學科：	骨髓/週邊血幹細胞移植、癌症化學治療、輸血醫學
專科證書：	中華民國內科專科醫師 中華民國血液病專科醫師 中華民國腫瘤內科專科醫師
專科學會：	中華民國內科醫學會 中華民國血液病醫學會 中華民國癌症醫學會 中華民國血液及骨髓移植學會 中華民國輸血醫學會 美國血庫學會 (AABB) 國際輸血學會 (ISBT) 國際實驗血液學會 (ISEH) 美國血液病學會 (ASH)
通訊處：	台北市石牌路二段201號台北榮民總醫院血液腫瘤科
E-mail：	chtzeng@vghtpe.gov.tw
代表著作：

1. Tzeng CH, Lyou JY, Chen YR, Hu HY, Lin JS, Wang SY, and Lee JCL. Determination of sibship by polymerase chain reaction-amplified short tandem repeat analysis in Taiwan. Transfusion 2000;40:840-5.
2. Tzeng CH, Lin JS, Chen PM, Hu HY, Lyou JY, Chen YR. Allogeneic peripheral blood stem cell transplantation: The Taiwan experience. Transfusion 1997;37:244-6.
3. Tzeng CH, Lin JS, Lee JCI, Yung CH, Hu HY, and Chen PM. Transfusion of donor peripheral blood buffy coat cells as effective treatment for relapsed acute leukemia after transplantation of allogeneic bone marrow or peripheral blood stem cells from the same donor. Transfusion 1996;36:685-90.
4. Tzeng CH, Chen pM, Fan S, Liu JH, Chiou TJ, and Hsieh RK. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors. Bone Marrow Transpl 1996; 18:273-7.
5. Tzeng CH, Hsieh RK, Fan FS, Liu JH, Liu JM, Liu CJ, Chen KY, Yung CH, Wang SY, Wang SR, Chiou TJ, Chen PM. Bone marrow transplantation for severe aplastic anemia - a study of twenty-one Chinese patients in Taiwan. Transplantation 1992;53:569-74.

1. Liu JH. Multiple drug resistance: An obstacle to the treatment of renal cell carcinoma. J Surg Asso ROC 1997;30:141-2.
2. Liu JH, et al. Retrovirally transduced ribozymes supress the growth of chronic myeloid leukemic cell line. Blood 1996;88(10):816a.
3. Liu JH, Mu ZM, Chang KS. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J Exp Med 1995;181:1965-73.
4. Liu JH, Yang MH, Fan FS, Yen CC, Wang WS, Chang YH, Chen KK, Chen PM. Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: A phase II study. Urology 2001; 57: 650-4.
5. Hsiao LT, Liu JH, Yen CC, Wang WS, Fan FS, Chiou TJ, Chen PM. Relapse of Graves' disease after successful allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28:1151-3.

1. Wang WS, Chen PM, Chiou TJ, Liu JH, Lin JK, Lin TC, Wang HS, Su Y. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma. Clin Cancer Res 2007; 13:3597-604.
2. Wang WS, Chen PM, Wang HS, Liang WY, Su Y. Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis 2006; 27:1113-20.
3. Wang WS, Chen PM, Hsiao HL, Wang HS, et al. Overexpression of the thymosin β-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 2004; 23:6666-71.
4. Wang WS, Chen PM, Hsiao HL, Ju SY, Su Y. Overexpression of the thymosin β-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 2003; 22:3297-306.
5. Wang WS, Chen PM, Su Y. Colorectal carcinoma: from tumorigenesis to treatment. Cell Mol Life Sci 2006; 63:663-71.

1. Chau WK, Law P. Effect of L-phenylalamine methyl ester on the colony formation of hematopoietic progenitor cells from human bone marrow. Int J Cell Clon 1991; 9: 211-9.
2. Chau WK, Lin CK, Chow MP, Wang SY, Liu JM, Ho CH, Chiu CF, Hsu HC, Tan TD, Chan WK, Peng-Whang J. Recombinant human granulocyte colony-stimulating factor and/or autologous peripheral blood stem cell transplantation as a rescue for sequential high-dose combination chemotherapy: a preliminary report. Chin Med J (Taipei) 1994; 54(5): 312-20.
3. Chau WK, Shih CM, Choo KB, et al. Detection of common Taiwanese b-thalassemia mutations by primer-directed mutagenesis of amplification created restriction sites. Advances In Therapy 1997.

1. Yen CC, Tung SL, Hsieh RK, Chiou TJ, Liu JH, Wang WS, Chen PM. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): Low palliative benefit and high treatment-related toxicity. Jpn J Clin Oncol 1997;27:316-20.
2. Yen CC, Chen PM, Chiou TJ, Hsieh RK. Orthoclone OKT3 for graft failure after allogeneic bone marrow transplantation: A case report. Chin Med J (Taipei) 1997;59:126-31.
3. Yen CC, Chen YJ, Chen JT, Hsia JY, Chen PM, Liu JH, Fan FS, Chiou TJ, Wang WS, Lin CH. Comparative genomic hybridization of esophageal squamous cell carcinoma: Correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001; 92:2769-77.
4. Yen CC, Tzeng CH, Liu JH, Chiou TJ, Hsieh RK, Wang WS, Chen PM. Acute myelomonocytic leukemia preceded by secondary amenorrhea and presenting with central diabetes insipidus: a case report. Chin Med J(Taipei) 1997; 60(4):213-8.

1. Hsiao LT, Chiou TJ, Liu JH, Chu CJ, Lin YC, Chao TC, Wang WS, Yen CC, Yang MH, Tzeng CH, Chen PM. Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2006 Jan;12(1):84-94.
2. Chen MH, Hsiao LT*, Chiou TJ, Liu JH, Gau JP, Teng HW, Wang WS, Chao TC, Yen CC, Chen PM. High prevalence of occult hepatitis B virus infectionin patients with B cell non Hodgkin lymphoma, Ann Hematol. 2008 Jun; 87(6): 475-80 (*corresponder)
3. Chen PM, Hsiao LT, Chen MH, Chang PM, Liu CY, Hong YC, Tzeng CH, Chiou TJ. Current status of hematopoietic stem cell transplantation in Taiwan. Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S133-S136.
4. Hsiao LT, Lin JT, Yu IT, Chiou TJ, Liu JH, Yen CC, Wang WS, Chen PM. High serum hepatocyte growth factor level in patients with non Hodgkin lymphoma. Eur J Haematol. 2003 May;70(5):282-9.
5. Hu YH, Hsiao LT*, Yang CF, Chiou TJ, Liu JH, Gau JP, Yen CC, Chou TY, Hsu WH, Chen PM, Tzeng CH. Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin's lymphoma: the single-institute experience in Taiwan. Ann Hematol 2009; 88(9):839-46. (*corresponder)